Effects of HIV Protease Inhibitors on Cardiac Conduction Velocity in Unselected HIV-Infected Patients (Q57314065)

6

0 references

author name string

B Charbit

1

0 references

E Gayat

2

0 references

P Voiriot

3

0 references

F Boccara

4

0 references

P-M Girard

Clinical Pharmacology & Therapeutics

5

0 references

language of work or name

English

0 references

publication date

3 August 2011

0 references

published in

0 references

volume

90

0 references

issue

3

0 references

page(s)

442-448

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/clpt.2011.131

0 references

cites work

A prospective evaluation of the effect of atazanavir on the QTc interval and QTc dispersion in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

The natural history of primary first-degree atrioventricular heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Antiarrhythmic agents: modulated receptor applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Relationships between heart rate and PR interval during physiological and pharmacological interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Gender differences in the electrophysiological characteristics of atrioventricular conduction system and their clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Electrocardiographic reference ranges derived from 79,743 ambulatory subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Electrocardiographic findings in a middle-aged African population in the Seychelles Islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Sodium channel blockers in the treatment of ventricular arrhythmias: different effects in the normal, ischaemic or failing heart?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Congestive heart failure induced by six of the newer antiarrhythmic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Prognostic Significance of Quantitative QRS Duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

First degree atrioventricular block

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

7 January 2021

Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

7 January 2021

Subject-specific heart rate dependency of electrocardiographic QT, PQ, and QRS intervals

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

7 January 2021

Age-associated changes in the components of atrioventricular conduction in apparently healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

7 January 2021

The electrocardiogram in obesity: statistical analysis of 1,029 patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

7 January 2021

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

7 January 2021

Rate-dependence of antiarrhythmic and proarrhythmic properties of class I and class III antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

7 January 2021

Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

7 January 2021

Amplification of flecainide-induced ventricular conduction slowing by exercise. A potentially significant clinical consequence of use-dependent sodium channel blockade

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.131

7 January 2021